Phil Ward

427 total citations
12 papers, 349 citations indexed

About

Phil Ward is a scholar working on Immunology, Oncology and Aerospace Engineering. According to data from OpenAlex, Phil Ward has authored 12 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Oncology and 4 papers in Aerospace Engineering. Recurrent topics in Phil Ward's work include Aluminum Alloy Microstructure Properties (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Phil Ward is often cited by papers focused on Aluminum Alloy Microstructure Properties (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Phil Ward collaborates with scholars based in United Kingdom, United States and Australia. Phil Ward's co-authors include H.V. Atkinson, A. R. Sanderson, David H. Kirkwood, Paul Griffiths, Jane A. McKeating, J. E. Grundy, P. Kapranos, J.M. Rodríguez-Ibabe, Liju Elias and John R. Lamb and has published in prestigious journals such as The Journal of Immunology, Acta Materialia and British Journal of Cancer.

In The Last Decade

Phil Ward

12 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phil Ward United Kingdom 6 191 182 95 87 59 12 349
G. Moine France 12 196 1.0× 275 1.5× 232 2.4× 11 0.1× 43 0.7× 25 619
Toko Tokunaga Japan 15 293 1.5× 96 0.5× 210 2.2× 25 0.3× 85 1.4× 49 661
Minha Park South Korea 15 152 0.8× 26 0.1× 85 0.9× 113 1.3× 59 1.0× 33 524
Yingju Li China 12 245 1.3× 106 0.6× 156 1.6× 42 0.5× 50 0.8× 36 492
Canyu Liu China 11 103 0.5× 13 0.1× 96 1.0× 55 0.6× 48 0.8× 35 377
Yuto Fukui Japan 11 96 0.5× 14 0.1× 123 1.3× 54 0.6× 31 0.5× 24 360
Hongjian Zhao China 13 274 1.4× 87 0.5× 193 2.0× 16 0.2× 169 2.9× 51 531
Yunwei Hao China 11 118 0.6× 16 0.1× 123 1.3× 43 0.5× 47 0.8× 15 411
Yanmeng Chen China 11 93 0.5× 31 0.2× 100 1.1× 73 0.8× 110 1.9× 20 359

Countries citing papers authored by Phil Ward

Since Specialization
Citations

This map shows the geographic impact of Phil Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil Ward more than expected).

Fields of papers citing papers by Phil Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phil Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil Ward. The network helps show where Phil Ward may publish in the future.

Co-authorship network of co-authors of Phil Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Phil Ward. A scholar is included among the top collaborators of Phil Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phil Ward. Phil Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Danila, Daniel C., C-C. Lin, Jia-Lin Lee, et al.. (2024). 1610P Circulating tumour cell (CTC) enumeration and overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC) treated with xaluritamig. Annals of Oncology. 35. S971–S972. 1 indexed citations
3.
Kelly, William Kevin, Daniel C. Danila, C-C. Lin, et al.. (2023). 264P Interim results from a phase I study of AMG 509 (xaluritamig), a STEAP1 x CD3 XmAb 2+1 immune therapy in patients with metastatic castration-resistant prostate cancer (mCRPC). Annals of Oncology. 34. S1576–S1576. 1 indexed citations
4.
Atkinson, H.V. & Phil Ward. (2008). Thixoforming of Hypereutectic Al/Si Automotive Pistons. Diffusion and defect data, solid state data. Part B, Solid state phenomena/Solid state phenomena. 141-143. 201–206. 4 indexed citations
5.
Ward, Phil, et al.. (2003). Response of semi-solid Sn-15 pct Pb to rapid shear-rate changes. Metallurgical and Materials Transactions A. 34(2). 409–417. 18 indexed citations
6.
Kapranos, P., Phil Ward, H.V. Atkinson, & David H. Kirkwood. (2000). Near net shaping by semi-solid metal processing. Materials & Design (1980-2015). 21(4). 387–394. 78 indexed citations
7.
Ward, Phil, et al.. (1996). Semi-solid processing of novel MMCs based on hypereutectic aluminium-silicon alloys. Acta Materialia. 44(5). 1717–1727. 115 indexed citations
8.
Grundy, J. E., Jane A. McKeating, Phil Ward, A. R. Sanderson, & Paul Griffiths. (1987). beta2 Microglobulin Enhances the Infectivity of Cytomegalovirus and When Bound to the Virus Enables Class I HLA Molecules To Be Used as a Virus Receptor. Journal of General Virology. 68(3). 793–803. 107 indexed citations
9.
Ward, Phil & A. R. Sanderson. (1983). The interchange of derivatives of human B2-microglobulin in HLA alloantigens.. PubMed. 48(1). 87–92. 8 indexed citations
10.
Sanderson, A. R. & Phil Ward. (1981). Epitope sites on human beta 2-microglobulin identified by xenogeneic polyclonal and monoclonal antisera.. PubMed. 44(1). 169–75. 4 indexed citations
11.
Lamb, John R., Edward D. Zanders, A. R. Sanderson, et al.. (1981). Antigen-specific helper factor reacts with antibodies to human beta  2 microglobulin.. The Journal of Immunology. 127(1). 231–234. 10 indexed citations
12.
Påhlman, Sven, et al.. (1979). Isolation of plasma-membrane components from cultured human pancreatic cancer cells by immuno-affinity chromatography of anti-β2M sepharose 6MB. British Journal of Cancer. 40(5). 701–709. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026